Drugs Have Undergone Benefit Assessment for Muscular Atrophy
No added benefit is proven, however, for older patients (types 2 and 3) and for presymptomatic infants whose genetic defects were detected in newborn screening. For onasemnogene…
Browsing Tag
risdiplam
Risdiplam Could Help Treat Spinal Muscular Atrophy Efficiently
In August 2020, the FDA approved the usage of risdiplam (Evrysdi) to treat SMA for adults and children two months and older. ‘Risdiplam helped improving motor functions among children with…
Roche announces launch of Evrysdi® (risdiplam) for treatment of SMA patients in …
Evrysdi® was first approved by the US FDA in August 2020 and is today available in India within 11 months of the US approval. Roche today announced the launch of Evrysdi® (risdiplam), the…